Product Class: PPARδ Receptor Agonist / Research Compound
Active Ingredient: Cardarine (GW 501516)
Concentration: 20 mg per tablet
Price For: 100 tablets
Brand: Cardarine
GW 501516, commonly known as Cardarine, is an investigational PPARδ (Peroxisome Proliferator-Activated Receptor Delta) agonist manufactured by Dragon Pharma. Each tablet contains 20 mg of Cardarine. Although frequently grouped with SARMs in bodybuilding discussions, Cardarine is not a selective androgen receptor modulator or anabolic steroid. Instead, it acts by activating PPARδ receptors involved in energy metabolism and fatty acid utilization.
Cardarine has been investigated for its potential effects on lipid metabolism, endurance performance, glucose utilization, and metabolic health. It remains an experimental compound and has not received approval for routine therapeutic use.
Cardarine has been investigated for its possible role in:
Within bodybuilding and endurance sports, Cardarine is commonly associated with:
GW 501516 selectively activates PPARδ receptors located throughout skeletal muscle and metabolic tissues. Activation of these receptors influences:
Unlike anabolic steroids, Cardarine does not bind to androgen receptors and does not stimulate testosterone production or muscle protein synthesis directly.
The relatively long half-life supports sustained receptor activation throughout the day following administration.
Within performance-enhancement discussions, Cardarine is commonly referenced alongside structured nutrition and endurance-focused training programs.
Nutrition, progressive resistance training, and cardiovascular exercise remain the primary factors influencing body composition outcomes.
Cardarine has no role in Hormone Replacement Therapy (HRT) or Testosterone Replacement Therapy (TRT). It does not influence testosterone production, estrogen balance, or androgen receptor activity. Individuals diagnosed with testosterone deficiency should receive evidence-based hormonal treatment under medical supervision.
Because Cardarine is non-androgenic, it is not associated with the virilization risks typically seen with anabolic steroids. However, its safety profile during pregnancy, breastfeeding, and long-term use has not been established. Women considering investigational compounds should consult a qualified healthcare professional.
GW 501516 Cardarine 20 mg is a non-hormonal PPARδ receptor agonist investigated for its influence on endurance performance, fatty acid metabolism, and metabolic health. Unlike anabolic steroids or SARMs, Cardarine acts through metabolic signaling pathways rather than androgen receptors, making it a unique research compound frequently discussed in body recomposition and endurance-focused protocols.
GW 501516 has primarily been investigated for metabolic health, endurance performance, fatty acid metabolism, and body recomposition research.
No. Cardarine is a PPARδ receptor agonist rather than a Selective Androgen Receptor Modulator (SARM).
Cardarine does not directly stimulate muscle protein synthesis like anabolic steroids. Improvements in body composition are generally associated with enhanced training capacity and metabolic efficiency.
Within bodybuilding discussions, Cardarine is frequently referenced alongside anabolic compounds during cutting phases. However, combining performance-enhancing substances should only be considered under appropriate medical supervision.
Please log in to write GW501516 review.